Literature DB >> 34123943

Myoclonus and Cerebellar Ataxia Associated with SARS-CoV-2 Infection: Case Report and Review of the Literature.

Nadia Mariagrazia Giannantoni1, Elia Rigamonti1, Francesca Irene Rampolli1, Lorenzo Grazioli-Gauthier1, Gilles Allali2,3, Gianluca Vanini1.   

Abstract

The current SARS-CoV-2/COVID-19 pandemic has led to a global health crisis. The clinical spectrum of SARS-CoV-2 infection ranges from asymptomatic infection to critical illness affecting almost every organ including the central and peripheral nervous systems. Myoclonus, a less expected and relatively unusual neurological complication, together with ataxia, has lately been associated with SARS-CoV-2 infection. We describe the case of a 67-year-old male patient, admitted to our hospital for interstitial bilateral pneumonia due to SARS-CoV-2 infection, who progressively developed general myoclonus and later cerebellar ataxia and gait disturbance. Given the timeline from COVID-19 systemic symptoms to neurological manifestations and the normal results of extensive and non-conclusive diagnostic work-up (blood test, lumbar puncture, EEG, cerebral MRI), a para-infectious encephalopathy related to SARS-CoV-2 was contemplated and a high dose of methylprednisolone was started with prompt symptom improvement. Further investigation and neuroepidemiological studies are needed to help define the mechanism of neuroinvasion and the entire spectrum of neurological manifestations of SARS-CoV-2 infection, even in mildly affected patients, in terms of prevention, treatment and possible neurological sequelae. LEARNING POINTS: SARS-CoV-2 infection can be related to neurological symptoms and sequelae.Myoclonus, specifically when associated with ataxia, might represent the expression of COVID-19-related encephalopathy.Myoclonus associated with SARS-CoV-2 infection mostly responds to treatment with steroids. © EFIM 2021.

Entities:  

Keywords:  SARS-CoV-2 infection; ataxia; differential diagnoses; myoclonus

Year:  2021        PMID: 34123943      PMCID: PMC8191357          DOI: 10.12890/2021_002531

Source DB:  PubMed          Journal:  Eur J Case Rep Intern Med        ISSN: 2284-2594


  15 in total

Review 1.  Extrapulmonary manifestations of COVID-19.

Authors:  Aakriti Gupta; Mahesh V Madhavan; Kartik Sehgal; Nandini Nair; Shiwani Mahajan; Tejasav S Sehrawat; Behnood Bikdeli; Neha Ahluwalia; John C Ausiello; Elaine Y Wan; Daniel E Freedberg; Ajay J Kirtane; Sahil A Parikh; Mathew S Maurer; Anna S Nordvig; Domenico Accili; Joan M Bathon; Sumit Mohan; Kenneth A Bauer; Martin B Leon; Harlan M Krumholz; Nir Uriel; Mandeep R Mehra; Mitchell S V Elkind; Gregg W Stone; Allan Schwartz; David D Ho; John P Bilezikian; Donald W Landry
Journal:  Nat Med       Date:  2020-07-10       Impact factor: 53.440

Review 2.  Myoclonic Disorders.

Authors:  Olaf Eberhardt; Helge Topka
Journal:  Brain Sci       Date:  2017-08-14

3.  The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings.

Authors:  Ross W Paterson; Rachel L Brown; Laura Benjamin; Ross Nortley; Sarah Wiethoff; Tehmina Bharucha; Dipa L Jayaseelan; Guru Kumar; Rhian E Raftopoulos; Laura Zambreanu; Vinojini Vivekanandam; Anthony Khoo; Ruth Geraldes; Krishna Chinthapalli; Elena Boyd; Hatice Tuzlali; Gary Price; Gerry Christofi; Jasper Morrow; Patricia McNamara; Benjamin McLoughlin; Soon Tjin Lim; Puja R Mehta; Viva Levee; Stephen Keddie; Wisdom Yong; S Anand Trip; Alexander J M Foulkes; Gary Hotton; Thomas D Miller; Alex D Everitt; Christopher Carswell; Nicholas W S Davies; Michael Yoong; David Attwell; Jemeen Sreedharan; Eli Silber; Jonathan M Schott; Arvind Chandratheva; Richard J Perry; Robert Simister; Anna Checkley; Nicky Longley; Simon F Farmer; Francesco Carletti; Catherine Houlihan; Maria Thom; Michael P Lunn; Jennifer Spillane; Robin Howard; Angela Vincent; David J Werring; Chandrashekar Hoskote; Hans Rolf Jäger; Hadi Manji; Michael S Zandi
Journal:  Brain       Date:  2020-10-01       Impact factor: 13.501

Review 4.  Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic.

Authors:  Maryam Sharifian-Dorche; Philippe Huot; Michael Osherov; Dingke Wen; Alexander Saveriano; Paul S Giacomini; Jack P Antel; Ashkan Mowla
Journal:  J Neurol Sci       Date:  2020-08-07       Impact factor: 3.181

5.  Myoclonus and Cerebellar Ataxia Following COVID-19.

Authors:  Femke Dijkstra; Tobi Van den Bossche; Barbara Willekens; Patrick Cras; David Crosiers
Journal:  Mov Disord Clin Pract       Date:  2020-09-28

6.  Movement Disorders in COVID-19: Whither Art Thou?

Authors:  Howard L Geyer; David M Kaufman; Raminder K Parihar; Mark F Mehler
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2020-08-12

7.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

8.  Myoclonus in Patients With Coronavirus Disease 2019: A Multicenter Case Series.

Authors:  Pria Anand; Asma Zakaria; Karima Benameur; Charlene Ong; Maryann Putman; Sarah O'Shea; David Greer; Anna M Cervantes-Arslanian
Journal:  Crit Care Med       Date:  2020-11       Impact factor: 9.296

Review 9.  Characteristics of SARS-CoV-2 and COVID-19.

Authors:  Ben Hu; Hua Guo; Peng Zhou; Zheng-Li Shi
Journal:  Nat Rev Microbiol       Date:  2020-10-06       Impact factor: 78.297

View more
  3 in total

Review 1.  Movement Disorders Induced by SARS-CoV-2 Infection: Protocol for a Scoping Review.

Authors:  Elena Cecilia Rosca; Zsolt Vastag; Onanong Phokaewvarangkul; Jirada Sringean
Journal:  J Clin Med       Date:  2022-02-10       Impact factor: 4.241

Review 2.  A Breakdown of Immune Tolerance in the Cerebellum.

Authors:  Christiane S Hampe; Hiroshi Mitoma
Journal:  Brain Sci       Date:  2022-02-28

3.  Temporal Changes in Brain Perfusion in a Patient with Myoclonus and Ataxia Syndrome Associated with COVID-19.

Authors:  Kenta Osawa; Atsuhiko Sugiyama; Akiyuki Uzawa; Shigeki Hirano; Tatsuya Yamamoto; Masahiko Nezu; Nobuyuki Araki; Hiroki Kano; Satoshi Kuwabara
Journal:  Intern Med       Date:  2022-02-01       Impact factor: 1.282

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.